Bios Capital Management manages investments for private funds, focusing on early-stage and growth-stage biotech and medical device companies. Bios investigates, analyzes, and negotiates potential investments, monitors performance, and advises on dispositions. The funds are offered to accredited and qualified purchasers. Investment strategies are not tailored to individual investors in a fund.
Assets Under Management$270M
Clients24
Advisors1
Avg. per Client$11M
Avg. per Advisor$270M
Fee Structure
Investment management only (planning not offered)
Bios Capital Management does not directly manage investments for individual investors. It manages investments for private funds, and investors in those funds pay management fees and carried interest as outlined in the fund's offering documents. These fees are negotiated between Bios and each fund.
Loading...